Intra-Cellular Therapies Inc. a Johnson & Johnson (“J&J”) company is headquartered in Bedminster, NJ. Founded on Nobel-prize winning research, we launched our first commercial product in CNS in 2020 and received approval for an expanded indication in 2021. We have a strong pipeline with projects in preclinical development stage through Phase III. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all...
Intra-Cellular Therapies Inc. a Johnson & Johnson (“J&J”) company is headquartered in Bedminster, NJ. Founded on Nobel-prize winning research, we launched our first commercial product in CNS in 2020 and received approval for an expanded indication in 2021. We have a strong pipeline with projects in preclinical development stage through Phase III. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all...
Intra-Cellular Therapies Inc. a Johnson & Johnson (“J&J”) company is headquartered in Bedminster, NJ. Founded on Nobel-prize winning research, we launched our first commercial product in CNS in 2020 and received approval for an expanded indication in 2021. We have a strong pipeline with projects in preclinical development stage through Phase III. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all...
Intra-Cellular Therapies Inc. a Johnson & Johnson (“J&J”) company is headquartered in Bedminster, NJ. Founded on Nobel-prize winning research, we launched our first commercial product in CNS in 2020 and received approval for an expanded indication in 2021. We have a strong pipeline with projects in preclinical development stage through Phase III. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all...
Intra-Cellular Therapies Inc. a Johnson & Johnson (“J&J”) company is headquartered in Bedminster, NJ. Founded on Nobel-prize winning research, we launched our first commercial product in CNS in 2020 and received approval for an expanded indication in 2021. We have a strong pipeline with projects in preclinical development stage through Phase III. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all...
Intra-Cellular Therapies Inc. a Johnson & Johnson (“J&J”) company is headquartered in Bedminster, NJ. Founded on Nobel-prize winning research, we launched our first commercial product in CNS in 2020 and received approval for an expanded indication in 2021. We have a strong pipeline with projects in preclinical development stage through Phase III. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all...
About my client. My client is a 28 Billion dollar market cap company and one of the largest pioneers in Biosilimars, aiming for 22 commercialized products by 2030 with 13 novel drugs in development and launching 4 in 2025. They are committed to driving innovation in the healthcare sector through the development and commercialization of biologics and biosimilars. Their mission is to enhance patient access to high-quality medications while fosterin...
About my client. My client is a 28 Billion dollar market cap company and one of the largest pioneers in Biosilimars, aiming for 22 commercialized products by 2030 with 13 novel drugs in development and launching 4 in 2025. They are committed to driving innovation in the healthcare sector through the development and commercialization of biologics and biosimilars. Their mission is to enhance patient access to high-quality medications while fosterin...
This territory includes Forest Hills, Jamaica, Ozone Park, Kew Gardens and the immediate surrounding areas. Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Our...
This territory includes Forest Hills, Jamaica, Ozone Park, Kew Gardens and the immediate surrounding areas. Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Our...
Intra-Cellular Therapies Inc. a Johnson & Johnson (“J&J”) company is headquartered in Bedminster, NJ. Founded on Nobel-prize winning research, we launched our first commercial product in CNS in 2020 and received approval for an expanded indication in 2021. We have a strong pipeline with projects in preclinical development stage through Phase III. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all...
